Vander Elst, N., Bellemans, J., Lavigne, R., Briers, Y., & Meyer, E. (2024). Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis. Applied Microbiology & Biotechnology, 108(1), 1. https://doi.org/10.1007/s00253-023-12820-w
Chicago Style (17th ed.) CitationVander Elst, Niels, Julie Bellemans, Rob Lavigne, Yves Briers, and Evelyne Meyer. "Endolysin NC5 Improves Early Cloxacillin Treatment in a Mouse Model of Streptococcus Uberis Mastitis." Applied Microbiology & Biotechnology 108, no. 1 (2024): 1. https://doi.org/10.1007/s00253-023-12820-w.
MLA (9th ed.) CitationVander Elst, Niels, et al. "Endolysin NC5 Improves Early Cloxacillin Treatment in a Mouse Model of Streptococcus Uberis Mastitis." Applied Microbiology & Biotechnology, vol. 108, no. 1, 2024, p. 1, https://doi.org/10.1007/s00253-023-12820-w.